Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Farmers Insurance
McKinsey
Chinese Patent Office
AstraZeneca
Harvard Business School
QuintilesIMS
Fish and Richardson
Express Scripts

Generated: August 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091691

« Back to Dashboard

NDA 091691 describes BRIMONIDINE TARTRATE, which is a drug marketed by Akorn, Bausch And Lomb, Indoco Remedies, Sandoz Inc, and Teva Parenteral, and is included in six NDAs. It is available from six suppliers. Additional details are available on the BRIMONIDINE TARTRATE profile page.

The generic ingredient in BRIMONIDINE TARTRATE is brimonidine tartrate. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
Summary for 091691
Tradename:BRIMONIDINE TARTRATE
Applicant:Indoco Remedies
Ingredient:brimonidine tartrate
Patents:0
Pharmacology for NDA: 091691
Mechanism of ActionAdrenergic alpha-Agonists
Medical Subject Heading (MeSH) Categories for 091691
Suppliers and Packaging for NDA: 091691
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BRIMONIDINE TARTRATE brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 091691 ANDA Osmotica Pharmaceutical Corp. 42843-501 N 42843-501-05
BRIMONIDINE TARTRATE brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 091691 ANDA Osmotica Pharmaceutical Corp. 42843-501 N 42843-501-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.2%
Approval Date:Nov 18, 2014TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Chubb
Moodys
Boehringer Ingelheim
Chinese Patent Office
US Army
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.